1x1

Tuesday, October 15, 2002
=Subscribers Only

 THE STAT

26

Percentage of wireless customers who use their cell phones to take pictures

More Vitals
On Phone Usage >>

COLUMNS FORUMS NEWSLETTERS PERSONAL FINANCE SEARCH SPECIAL REPORTS TOOLS VIDEO VIEWS

Customer Service
Contact Us
Advertising
Conferences
Permissions & Reprints
Marketplace

Subscribe to BW




How High Tech Is Operating on Medicine
Doctors and machines that move as one, pacemakers that collect and transmit data, seamless support systems... Here's a peek at tomorrow's health care

Focusing on Picture-Perfect Diagnoses
As noninvasive imaging improves, more patients agree to tests. That means ailments are identified sooner -- and cost less to treat

Gene Therapy's Unsteady First Steps
Initial experiments have led to both positive and disturbing results, forcing scientists to temper, but hardly abandon, their expectations

A Tool-and-Die Maker for Genesmiths
Finding the DNA quirks that cause diseases was a pricey, laborious process until Illumina developed its robotic lab workers

Waiting for the Genomics Payoff
David Barker, chief scientist at Illumina, explains how his company's technology works -- and why investors need to be patient

Automating the Hospital Pharmacy
McKesson CEO John Hammergren says his "robotic" systems let doctors, nurses, and pharmacists concentrate on the tough jobs

Inside J&J's Innovation Machine
From liquid bandages to sophisticated time-release medication, CFO Robert Garretta explains health-care giant's R&D strategy




BIOTECH BEAT
How Merck Is Treating the Third World
CEO Ray Gilmartin says the drugmaker's experience fighting river blindness can be applied to AIDS but that the industry can't do it alone
(Oct. 10, 2002)

STREET WISE
The Kinks In Genentech's Pipeline
The biotech giant has shrugged off breast-cancer drug Avastin's disappointing clinical trials. Can investors afford to be as sanguine?
(Sept. 19, 2002)

AMERICA'S FUTURE
Biotech for Boomers
Over the next few years, new treatments for cancer, Alzheimer's, and cardiovascular conditions will help some patients manage once-deadly diseases
(Sept. 19, 2002)

GURUS OF MEDICAL TECH
A Marriage of Nanotech and Biotech
Harvard chemistry professor George Whitesides' latest quest is getting tiny nonliving structures to assemble themselves
(July 30, 2002)

TODAY'S MOST POPULAR STORIES

  1. Retailers: New Strategies for this Holiday Season
  2. Five Deadly Interview Mistakes
  3. At General Motors, Loss Reduction Is a Good Start
  4. China's End Run Around the U.S.
  5. Germans Catch the iPhone Apps Wave

Get Free RSS Feed >>
  MARKET INFO

Portfolio Service Update

Stock Lookup

Enter name or ticker